Learn more

UNIV GIESSEN JUSTUS LIEBIG

Overview
  • Total Patents
    153
  • GoodIP Patent Rank
    240,739
About

UNIV GIESSEN JUSTUS LIEBIG has a total of 153 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Germany and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV ALBERTA, ISIS INNOVATION and CANCER RES VENTURES LTD.

Patent filings per year

Chart showing UNIV GIESSEN JUSTUS LIEBIGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Schreiner Peter R 21
#2 Gessler Tobias 19
#3 Schmehl Thomas 19
#4 Beck-Broichsitter Moritz 11
#5 Wanka Lukas 11
#6 Fokin Andrey A 10
#7 Polity Angelika 8
#8 Meyer Bruno K 6
#9 Khalil Faiza 6
#10 Maison Wolfgang 6

Latest patents

Publication Filing date Title
EP2634246A1 Device and method for indentifying, separating and/or cell type-specific manipulation of at least one cell of a cell system and microorganisms
EP2631954A1 Copper oxide (Cu2O, Cu4O3 or CuO) heterojunctions, in particular for solar cells and tandem cells
EP2626057A1 Tin-enriched adhesive system for connecting filling material with dental tissue and for coating dental tissue
WO2012051988A2 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action
DE102011053469A1 Process for making a beverage or beverage base
EP2526927A1 Biocompatible nano- and microparticles coated with stabilisers for pulmonary application
EP2526926A1 Biocompatible nanopolymer particles with active agents for pulmonary application
DE102011018221A1 Apparatus and method for obtaining sperm in animals
EP2399926A1 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents
DE102010047583A1 Diagnosis of specific cardiovascular diseases, comprises determining the concentration of metabolites of B-type natriuretic peptide (BNP)1-32 in a sample of an individual to be examined
DE102010047582A1 New receptor agonists exhibiting an activity e.g. diuresis, and influencing cyclic guanosine monophosphate, are natriuretic peptide receptors A and B binders, useful for prevention and/or therapy of disease e.g. pulmonary fibrosis
EP2488452A1 Re-dispersible metal oxide nanoparticles and method of making them
EP2428517A1 Synthesis of tripodal bisphosphonate derivatives with an adamantyl base for functionalising surfaces
EP2428518A1 Synthesis of tripodal bisphosphonate derivatives with a flexible base for functionalising surfaces
EP2423946A1 Production of a p-conducting ZnO semiconductive layer
DE102010032482A1 New receptor agonist having renin-suppressing activity, antihypertrophic activity and influence of second messenger cyclic guanosine monophosphate during vasodilation, natriuresis and diuresis, useful to treat e.g. nephrotic syndrome
EP2407150A1 Polymer nano and micro particles for the maintenance of the low surface tension in the lung and for the protection of the pulmonary surfactant
DE102010024503A1 Detecting infection with Mycobacterium avium subsp. paratuberculosis in ruminant, comprises quantifying marker in sample and comparing sample to be analyzed with reference values and values of positive and/or negative control
EP2388588A1 Method and quick test for determining the fertility of sperms
EP2385120A1 Use of anti-miRNA antisense oligonucleotides for the treatment of pulmonary hypertension